| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.5B | $9.8B | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.2B | $2.8B | $11.5B | $1.1B | $0.5B | $0.5B | $0.5B | $0.4B |
| EPS (Basic) | $165.24 | $189.42 | $785.14 | $67.47 | $53.88 | $47.50 | $41.05 | $33.53 |
| EPS (Diluted) | $165.24 | $189.41 | $784.51 | $67.40 | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $229.7B | $223.7B | $213.8B | $109.3B | $58.3B | $50.0B | $39.8B | $35.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $9.0B | — | $0.4B | $0.3B |
| Total Liabilities | $207.5B | $201.5B | $192.5B | $99.6B | $53.6B | $45.7B | $36.2B | $31.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $22.2B | $22.2B | $21.3B | $9.7B | $4.7B | $4.2B | $3.6B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $3.0B | $2.7B | $2.8B | $-0.3B | $0.3B | $0.5B | — |
| Investing Cash Flow | $-5.6B | $-10.2B | $2.4B | $0.1B | $-7.6B | $-9.9B | $-1.6B | — |
| Capital Expenditures | $0.7B | $0.4B | $0.4B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $2.7B | $7.1B | $-4.7B | $-2.7B | $7.8B | $9.5B | $1.1B | — |